EucapSys stands out as the exclusive compact device that empowers clinicians to perform the Eucapnic Voluntary Hyperpnea (EVH) test on patient, offering an alternative approach to conventional indirect or direct bronchial challenge tests like exercise challenges or methacholine challenge test.
Unlike other challenge tests, EucapSys does not require any medication
EucapSys is recognized as the exceptional and benchmark solution for evaluating exercise-induced bronchoconstriction (EIB) in patients
EucapSys is pioneering as the first commercially available system that extends the applicability of EVH to a wide range of users
EucapSys mixes the eucapnic gas concentration by itself, making the test more affordable and independent from expensive gas mixtures
